ArticleCureus2025
The Role of Double J Stenting in Nonobstructive Acute Pyelonephritis With Acute Kidney Injury.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective There has been a paradigm shift in the clinical manifestations and renal outcomes of patients with nonobstructive acute pyelonephritis (NO-APN), with acute kidney injury (AKI) being a common complication. While the standard of care remains parenteral antibiotics, minimally invasive urologic procedures is still uncertain. This study aimed to assess the effectiveness of double J (DJ) stenting in patients with NO-APN with AKI in promoting renal recovery, assessed by improvements in creatinine and inflammatory markers. Methods This retrospective study examined the renal outcomes of patients with NO-APN and AKI admitted to a tertiary care hospital in Chennai, India. Patients were divided into two cohorts according to the treatment received: conservative management (Group A) and DJ stenting (Group B). Treatment outcomes were assessed in terms of renal recovery, sepsis resolution, and length of hospital stay. Additionally, a pre-specified subgroup analysis was conducted comparing Kidney Disease: Improving Global Outcomes (KDIGO) Stage III AKI patients between Group A and Group B. Results There was no statistically significant difference between the conservative (Group A) and intervention (Group B) patients in terms of overall renal outcomes. However, in the subgroup analysis of Stage III AKI patients, those who underwent DJ stenting (Group B) demonstrated better treatment outcomes than the conservative group. There was a statistically significant reduction in mean total leukocyte count (TLC) (from 14,937.9 ± 5,275.5 cells/mm³ at admission to 11,656.3 ± 4,936.1 cells/mm³ at discharge,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.